Islet Transplantation as a Treatment for Diabetes - A Work in Progress

New England Journal of Medicine

Volumn 350, Issue 7, 2004, Pages 694-705

  Robertson, R Paul ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DISEASE CONTROL; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT PLANNING; HISTORY; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT;

DIABETES MELLITUS, TYPE 1; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 1442265579     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra032425     Document Type: Review

References (106)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2001. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2001. Los Angeles: UCLA Immunogenetics Center, 2002: 41-72.
3. Robertson RP. Pancreatic and islet transplantation for diabetes - cures or curiosities? N Engl J Med 1992;327:1861-8.
4. Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990;39:802-6.
5. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997;42:727-36.
6. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75.
7. Fiorina P, LaRocca E, Venturini M, et al. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001;50:496-501.
8. Larsen JL, Ratanasuwan T, Burkman T, et al. Carotid intima media thickness decreases after pancreas transplantation. Transplantation 2002;73:936-40.
9. Jukema JW, Smets YF, van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002;25:906-11.
10. Piehlmeier W, Bullinger M, Nusser J, et al. Quality of life in type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function. Diabetologia 1991;34: Suppl 1:S150-S157.
11. Milde FK, Hart LK, Zehr PS. Quality of life of pancreatic transplant recipients. Diabetes Care 1992;15:1459-63.
12. Gross CR, Zehrer CL. Impact of the addition of a pancreas to quality of life in uremic diabetic recipients of kidney transplants. Transplant Proc 1993;25:1293-5.
13. Barrou B, Baldi A, Bitker MO, Squifflet JP, Gruessner RW, Sutherland DE. Pregnancy after pancreas transplantation: report of four new cases and review of the literature. Transplant Proc 1995;27:303-4.
14. Kairaitis LK, Nankivell BJ, Lawrence S, et al. Successful obstetric outcome after simultaneous pancreas and kidney transplantation. Med J Aust 1999;170:368-70.
15. Williams PW. Notes on diabetes treated with extract and by grafts of sheep's pancreas. Br Med J 1894;2:1303-4.
16. Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972;72:175-86.
17. Sutherland DE, Matas AJ, Goetz FC, Najarian JS. Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes 1980;29:Suppl 1:31-44.
18. Najarian JS, Sutherland DE, Baumgartner D, et al. Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg 1980; 192:526-42.
19. Largiader F, Kolb E, Binswanger U. A long-term functioning human pancreatic islet allotransplant Transplantation 1980; 29:76-7.
20. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh RE, Sutherland DER, Robertson RP. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 1992;327:220-6.
21. Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995;222:562-79.
22. Scharp DW, Lacy PE, Santiago JV, et al. Insulin independence after islet transplantation into type 1 diabetic patient. Diabetes 1990;39:515-8.
23. Tzakis AG, Ricordi C, Alejandro R, et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990;336:402-5.
24. Warnock GL, Kneteman NM, Ryan E, Seelis RE, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991;34:55-8.
25. Scharp DW, Lacy PE, Santiago JV, et al. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991;51:76-85.
26. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:89-95.
27. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 1993; 341:19-21.
28. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-1.
29. Carroll PB, Rilo HL, Alejandro R, et al. Long-term (>3-year) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. Transplantation 1995;59:875-9.
30. Luzi L, Hering BJ, Socci C, et al. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996;97:2611-8.
31. Alejandro R, Lehmann R, Picordi C, et al. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 1997; 46:1983-9.
32. Secchi A, Socci C, Maffi P, et al. Islet transplantation in IDDM patients. Diabetologia 1997;40:225-31.
33. Keymeulen B, Ling Z, Gorus FK, et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 1998;41:452-9.
34. Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 2000;659:1115-23.
35. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
36. ITR newsletter 9. Vol. 8. No. 1. June 2001:1-20. (Giessen, Germany: International Islet Transplant Registry, University Hospital Giessen.) (Accessed January 20, 2004, at www.med.uni-giessen.de/itr/newsletter/no_9/news_9.pdf.)
37. Morrison H. Contributions to the microscopic anatomy of the pancreas by Paul Langerhans. Bull Inst Hist Med 1937;5:259-97.
38. Samols E, Stagner JI, Ewart RB, Marks V. The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas. J Clin Invest 1988;82:350-3.
39. Brunicardi FC, Stagner-Weir S, et al. Microcirculation of the islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes 1996;45:385-392.
40. Markmann JF, Deng S, Desai NM, et al. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 2003;75:1423-9.
41. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37:413-20.
42. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988;46:457-60.
43. 1) method of pancreas preservation on human islet isolation, as assessed by the Edmonton isolation protocol. Transplantation 2002;74: 1414-9.
44. Hering BJ, Matsumoto I, Sawada T, et al. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 2002;74:1813-6.
45. Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002;74: 1809-11.
46. Gores PF, Sutherland DE. Pancreatic islet transplantation:is purification necessary? Am J Surg 1993;166:538-42.
47. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000;97:7999-8004.
48. Brendel MD, Kong SS, Alejandro R, Mintz DH. Improved functional survival of human islets of langerhans in three-dimensional matrix culture. Cell Transplant 1994; 3:427-35.
49. Gaber AO, Fraga DW, Callicutt CS, Gerling IC, Sabek OM, Kotb MY. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation 2001; 72:1730-6.
50. Billaudel B, Sutter BC. Immediate in-vivo effect of corticosterone on glucose-induced insulin secretion in the rat. J Endocrinol 1982;95:315-20.
51. Robertson RP. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986;35:1016-9.
52. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes 1986;35: 1049-52.
53. Gold G, Qian RL, Grodsky GM. Insulin biosynthesis in HIT cells: effects of glucose forskolin, IBMX, and dexamethasone. Diabetes 1988;37:160-5.
54. Draznin B, Metz SA, Sussman KE, Leitner JW. Cyclosporin-induced inhibition of insulin release: possible role of voltage-dependent calcium transport channels. Biochem Pharmacol 1988;37:3941-5.
55. Chandrasekar B, Mukherjee SK. Effect of prolonged administration of cyclosporin A on (pro)insulin biosynthesis and insulin release by rat islets of Langerhans. Biochem Pharmacol 1988;37:3609-11.
56. Gillison SL, Bartlett ST, Curry DL. Synthesis-secretion coupling of insulin: effect of cyclosporin. Diabetes 1989;38:465-70.
57. Philippe J, Missotten M. Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells. Endocrinology 1990;127:1640-5.
58. Gillison SL, Bartlett ST, Curry DL. Inhibition by cyclosporine of insulin secretion - a beta cell-specific alteration of islet tissue function. Transplantation 1991;52:890-5.
59. Ricordi C, Zeng YJ, Alejandro R, et al. In vivo effect of FK506 on human pancreatic islets. Transplantation 1991;52:519-22.
60. Strasser S, Alejandro R, Shapiro ET, Picordi C, Todo S, Mintz DH. Effect of FK506 on insulin secretion in normal dogs. Metabolism 1992;41:64-7.
61. Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 1993;56: 1486-90.
62. Fabian MC, Lakey JR, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation: in vitro and in vivo studies. Transplantation 1993; 56:1137-42.
63. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996;98: 2786-93.
64. Meredith M, Li G, Metz SA. Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochem Pharmacol 1997;53:1873-82.
65. Davani B, Khan A, Hult M, et al. Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J Biol Chem 2000; 275:34841-4.
66. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 drugs and Wistar rat islets. Transplantation 2002;73:353-7.
67. Oetjen E, Baun D, Beimesche S, et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. Mol Pharmacol 2003; 63:1289-95.
68. Oetjen E, Grapentin D, Blume R, et al. Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. Naunyn Schmiedebergs Arch Pharmacol 2003;367:227-36.
69. Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab 2002;87:5418-23.
70. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab 2002;87:5424-9.
71. Kendall DM, Teuscher AU, Robertson RP. Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes 1997;46:23-7.
72. Gupta V, Wahoff DC, Rooney DP, et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 1997;46:28-33.
73. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002;51:3428-34.
74. Kin T, Korbutt GS, Rajotte RV. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 2003;3:281-5.
75. Robertson RP, Lafferty KJ, Haug CE, Weil R III. Effect of human fetal pancreas transplantation on secretion of C-peptide and glucose tolerance in type I diabetics. Transplant Proc 1987;19:2354-6.
76. Shapiro J. Eighty years after insulin: parallels with modern islet transplantation. CMAJ 2002;167:1398-400.
77. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741-9.
78. Hirshberg B, Rother KI, Digon BJ III, et al. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care 2003;26:3288-95.
79. Ault A. Edmonton's islet success tough to duplicate elsewhere. Lancet 2003;361: 2054.
80. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148-57.
81. Robertson RP, Kendall D. Islet transplantation 2003: questions about its future. Curr Opin Endocrinol Diabetes 2003;10: 128-32.
82. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 2001;50:47-50.
83. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 1997;46:1907-10.
84. Bosi E, Braghi S, Maffi P et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001;50:2464-71.
85. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994;43:1426-34.
86. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-9.
87. Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med 1994;97:535-42.
88. Luzi L, Perseghin G, Brendel MD, et al. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001; 50:277-82.
89. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001;233:463-501.
90. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 1990;322:898-903.
91. Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002;73:736-41.
92. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417-22.
93. Lanza RP, Butler DH, Borland KM, et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci U S A 1991;88:11100-4.
94. de la Tour D, Halvorsen T, Demeterco C, et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001;15:476-83.
95. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-94. [Erratum, Science 2001;293:428.]
96. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-94. [Erratum, Science 2001;293:428.]
97. Soria B, Skoudy A, Martin F. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 2001; 44:407-15.
98. Assady S, Maor G, Amit M, Itskovitz-Elder J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-7.
99. Zulewski H, Abraham BJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001;50:521-33.
100. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002;99:16105-10.
101. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA. Insulin staining of ES cell progeny from insulin uptake. Science 2003;299:363.
102. Kenyon NS, Fernandez LA, Lehmann R, et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999;48:1473-81.
103. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999;96:8132-7.
104. Contreras JL, Eckhoff DE, Cartner S, et al. Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. Transplantation 2000;69: 195-201.
105. Thomas JM, Contreras JL, Smyth CA, et al. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 2001;50:1227-36.
106. Fiorina P, Folli F, Bertuzzi F, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003;26:1129-36.